142 related articles for article (PubMed ID: 8779117)
1. [The use of nimodipine in elderly dementia patients].
Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
[TBL] [Abstract][Full Text] [Related]
2. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
Fritze J; Walden J
J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
[TBL] [Abstract][Full Text] [Related]
3. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta JM; Birks J
Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
[TBL] [Abstract][Full Text] [Related]
4. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta ; Birks J
Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
[TBL] [Abstract][Full Text] [Related]
5. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta JM; Birks J
Cochrane Database Syst Rev; 2000; 2002(2):CD000147. PubMed ID: 10796495
[TBL] [Abstract][Full Text] [Related]
6. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
[TBL] [Abstract][Full Text] [Related]
7. [The importance of nimodipine in treatment of dementia].
Eckert A
Pharm Unserer Zeit; 2005; 34(5):392-8. PubMed ID: 16180362
[No Abstract] [Full Text] [Related]
8. Nimodipine in subcortical vascular dementia trial.
Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
Zongfang Z; Wenjing L; Zhaomin C; Lei Z
Pak J Pharm Sci; 2020 Sep; 33(5(Special)):2405-2411. PubMed ID: 33832882
[TBL] [Abstract][Full Text] [Related]
10. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
Parnetti L; Senin U; Carosi M; Baasch H
Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
[TBL] [Abstract][Full Text] [Related]
11. Aging, dementia and calcium metabolism.
Kanowski S
J Neural Transm Suppl; 1998; 54():195-200. PubMed ID: 9850928
[TBL] [Abstract][Full Text] [Related]
12. Rivastigmine for subcortical vascular dementia.
Román GC
Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
[TBL] [Abstract][Full Text] [Related]
13. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
Kim JM; Lyons D; Shin IS; Yoon JS
Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.
Pantoni L; Rossi R; Inzitari D; Bianchi C; Beneke M; Erkinjuntti T; Wallin A
J Neurol Sci; 2000 Apr; 175(2):124-34. PubMed ID: 10831773
[TBL] [Abstract][Full Text] [Related]
15. [Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease].
Zhang JT
Yao Xue Xue Bao; 1993; 28(9):641-6. PubMed ID: 8010007
[No Abstract] [Full Text] [Related]
16. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
17. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of perospirone on aggressive behavior associated with dementia.
Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
[TBL] [Abstract][Full Text] [Related]
19. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
[TBL] [Abstract][Full Text] [Related]
20. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
